Autonomous Execution

DBS Bank and Visa are piloting “Visa Intelligent Commerce,” enabling AI agents to initiate and complete purchases on behalf of customers. This “agent-driven commerce” shifts transactions from human to AI execution, with banks retaining control through tokenization and approval workflows. The pilot focuses on routine purchases, aiming to integrate AI more deeply into financial operations while addressing security and trust concerns.

Agentic AI is transforming life sciences marketing, moving beyond basic prompts to autonomously manage complex initiatives. This shift could unlock significant economic value by 2028, with executives planning widespread integration. In pharmaceutical marketing, these AI agents can overcome fragmented data challenges, empowering sales reps with real-time intelligence and personalized engagement plans for healthcare professionals. Success hinges on “AI-ready data” for accelerated decision-making, scalable personalization, and measurable ROI, though regulatory hurdles remain.